Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,889
Total Claims
$1.7M
Drug Cost
498
Beneficiaries
$3,498
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+228%
Cost per patient vs peers
$3,498 vs $1,068 avg
+132%
Brand preference vs peers
20.8% vs 9.0% avg
Brand vs Generic
Brand: 2,223 claims · $1.5M
Generic: 8,444 claims · $246K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Icosapent Ethyl | 555 | $278K |
| Diclofenac Epolamine | 258 | $205K |
| Linaclotide | 137 | $97K |
| Cyclosporine | 105 | $84K |
| Tenofovir Alafenamide | 55 | $81K |
| Ubrogepant | 41 | $63K |
| Empagliflozin | 66 | $57K |
| Empagliflozin/Metformin Hcl | 66 | $51K |
| Denosumab | 29 | $50K |
| Lipase/Protease/Amylase | 40 | $49K |
| Semaglutide | 35 | $45K |
| Rsv Vacc, Pref A And Pref B/Pf | 112 | $36K |
| Diclofenac Sodium | 134 | $29K |
| Evolocumab | 44 | $28K |
| Atogepant | 18 | $27K |
Prescribing Profile
Patient Profile
73
Avg Age
54%
Female
1.16
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data